author-photo

Gema Bruixola

Instituto Politécnico Nacional

22

Papers

37

Citations

Citation Trend

Filter By

Papers (16) Sort By

Journal Conference Others

Phase II multicenter randomized trial to assess the efficacy and safety of first line nivolumab in combination with paclitaxel in subjects with R/M HNSCC unable for cisplatin-based chemotherapy (NIVOTAX): A TTCC study.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Observational, multicenter, prospective study to assess the impact on patients' outcome of a systematic screening of oncogenic drivers in advanced cancer: The GETHI XX-16 study.

2019 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
An internally validated new clinical and inflammation-based prognostic score for patients with advanced hepatocellular carcinoma treated with sorafenib

2018 Clinical & Translational Oncology
Show All
- Source
- Cite
- Save
Citations (10)
Neutrophil-to-lymphocyte ratio as a biomarker for prognosis in localized colorectal carcinoma

2016 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Bilateral pulmonary nodules after the successful treatment of a mediastinal seminoma

2015 International Journal of Cancer Therapy and Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Multimodality Treatment of Pediatric and Adult Patients With Ewing Sarcoma: A Single-institution Experience.

2015 Journal of Pediatric Hematology Oncology
Show All
- Source
- Cite
- Save
Citations (6)
Adjuvant chemoradiation in gastric cancer: long-term outcomes and prognostic factors from a single institution

2015 Tumori
Show All
- Source
- Cite
- Save
Citations (2)
2326 An internally validated new clinical prognostic score for patients with advanced hepatocellular carcinoma treated with sorafenib

2015 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (0)
Baseline neutrophil-to-lymphocyte ratio (NLR) and early toxicity as prognostic factors in advanced hepatocellular carcinoma patients treated with sorafenib.

2015 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
2325 A study of the representativity of the NCIC, PRODIGE and MPACT phase III trials of gemcitabine-erlotinib, FOLFIRINOX and gemcitabine-nab-paclitaxel in patients with advanced pancreatic cancer treated in a real-life setting

2015 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (0)